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Lehigh Valley Health Network, Allentown, Pa.
INTRODUCTION
  Biotin, a water-soluble B vitamin, is used for 
the metabolism of carbohydrates, fats, and 
amino acids. 
  Many laboratory tests that use biotin 
technology can be significantly altered in 
individuals taking high doses of biotin 
supplements (100-300mg/day).
CASE PRESENTATION
  A 68-year-old Caucasian female with a history of multiple sclerosis on 
300mg biotin daily presented with diarrhea, decreased appetite, and 
altered mental status. 
  The patient had a temperature of 96.1°F on admission. Less than five 
hours later she was hypothermic with a temperature of 93.2°F. Her vitals 
at that time were a pulse of 69, respiratory rate of 14, SpO2 of 100% on 
room air, and a blood pressure of 129/65. On exam, she was lethargic 
and unable to follow commands. 
  Lab studies revealed creatinine of 4.01mg/dL (baseline of 0.8mg/dL) and 
bicarbonate of 18 mmol/L (normal 23-31 mmol/L). Given her 
presentation, thyroid function tests (TFT) were ordered and resulted as 
TSH 0.02 uIU/mL (normal 0.36-3.74 uIU/mL) and free T4 greater than 
8.00 ng/dL (normal 0.76-1.46 ng/dL). 
  Repeat thyroid labs on day two showed TSH of 0.02 uIU/mL, free T3 of 
1.86 pg/mL (normal 2.30-4.20 pg/mL), total T3 of 0.7ng/mL (normal 
0.60-1.81 ng/mL), and total T4 of 7.2ng/dL (normal 4.5-10.9ug/dL). 
TPO autoantibody, thyroglobulin antibody, and thyroid stimulating 
immunoglobulin were negative. 
  While the patient’s labs were consistent with hyperthyroidism, she did not 
clinically examine thyrotoxic. 
  Further history revealed that biotin had been started by her outpatient 
neurologist for multiple sclerosis and had been held upon admission. The 
patient’s use of high dose 300mg biotin daily for multiple sclerosis was 
suspected to be the cause of the abnormal thyroid function tests. 
  Repeat free T4, on hospital day three, was 6.2 ng/dL. On hospital day 
four, free T4 normalized to 1.37 ng/dL with no intervention. 
  After treatment with IV fluids for acute kidney injury and discontinuing 
sedating medications, her clinical condition improved. 
Mechanism of biotin interference in Roche immunoassays. The 
Roche sandwich immunoassay employs a biotinylated antibody to 
the analyte (thyroid-stimulating hormone [TSH] in this example); 
therefore, excess free biotin displaces antigen-antibody complexes 
(Ab-Ag), which leads to less ruthenium (Ru2+)-conjugated 
antibody binding to the solid phase and false depression of 
analyte measurement. The Roche competitive immunoassay 
utilizes a complex of biotinylated analyte (thyroxine [T4] in this 
example) and microparticles with recombinant T4 (rT4) that 
displace the sample analyte being measured from an antibody-
conjugate with Ru2+. Excess free biotin also displaces Ab-Ag 
complex from the solid phase, producing false elevations in 
sample analyte measurements.
7/7/19 7/8/19 7/9/19 7/10/19 Reference Range
TSH 0.02 0.02 0.36-3.74 uIU/mL
Free T4 >8.00 >8.00 6.20 1.37 0.76-1.46 ng/dL
Thyroid Laboratory Results after Biotin was Stopped
DISCUSSION
  Our unique case illustrates the importance of understanding how 
medications and supplements can alter laboratory assays 
leading to test result errors. The lab studies consistent with 
severe thyrotoxicosis were confounded by an inconsistent clinical 
presentation in our patient. 
  Biotin, an easily accessible supplement, is being increasingly 
used in high doses as a part of the pharmacological 
management of multiple sclerosis. 
  The literature has demonstrated that when using the Roche 
assay for TFT measurement, biotin can falsely elevate free T4 
and falsely lower the TSH. Biotin interferes with the sandwich 
assay used for TSH measurement as well as the competitive 
immunoassay used for T4 measurement. 
  A high clinical suspicion of the degree of interaction between 
high dose biotin and TFT lab analysis is key. Our case 
exemplifies the importance of interpreting laboratory data with 
caution and clinically correlating it to each patient’s unique 
presentation. 
